Tag:
Alectos
Latest Headlines
Latest Headlines
Merck commits up to $289M for new Alzheimer's collaboration
Undaunted by its mixed results trying to come up with a new therapy for Alzheimer's, Merck has struck a $289 million deal with Canada's Alectos Therapeutics to collaborate on new molecules for the
